Clinical Trial Update: An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome [Phase 1]

View source ↗

Summary

An exploratory Phase 1 trial evaluating ketamine for Rett Syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Rett Syndrome | Phase 1 | Status: TERMINATED